Page 3 - Buzzing Stocks

Coffee Day Enterprises up for 5th day, hits 20% upper circuit; here's why

Shivakumar has family connections with CCD through his eldest daughter, Aisshwarya, who is the wife of Amartya Hegde. Amartya Hegde is the son of the late VG Siddhartha, who founded CCD in 1996.

Delta Corp share price tanks 18% today; what's behind the selloff?

Delta Corp share price:Today's selling pressure in Delta Corp was triggered after the Supreme Court ruled in favour of the government's retrospective levy of 28% GST on online gaming companies.

Wockhardt hits all-time high on CDSCO approval for antibiotic Zaynich

The buying on the counter came after the company received approval from the CDSCO for the import and marketing of Zaynich Zidebactam/Cefepime

Physicswallah gains 5% post Q4; loss narrows, revenue up 51% YoY

In the March quarter, Physicswallah reported a consolidated net loss year-on-year (Y-o-Y) of ₹74.89 crore, as compared to ₹293.1 crore

Zydus Lifesciences up 2% to 52-wk high on USFDA review nod, buyback tweak

The pharmaceutical company said the buyback price has been increased from ₹1,150 per equity share to ₹1,260 per equity share

Wipro rises 5% on expanded ServiceNow tie-up to scale agentic AI workflows

The buying on the counter came after Wipro announced an expanded partnership with ServiceNow to implement and scale agentic artificial intelligence (AI) workflows across core enterprise function

Aditya Infotech hits 10% upper circuit on strong Q4; FY27 guidance revised

Aditya Infotech Share: The stock was in demand after Aditya Infotech posted its Q4FY26 results and revised its FY27 guidance.

GMR Airports gains 6% after Q4 turnaround; JM Fin keeps buy for 17% upside

GMR Airports share price today: In Q4FY26, the company reported a net profit of ₹400.49 crore versus a loss of ₹252.66 crore incurred in the year-ago period.

Alkem Labs up 6% on Q4 beat; early Tolvaptan launch, tax cut cheer Street

In the March quarter, Alkem Laboratories reported a fall in consolidated net profit by 22.7 per cent year-on-year (Y-o-Y) for the fourth quarter (Q4) of the financial year 2025-26 (FY26) to ₹236 crore

Technical picks: Buy ACC, GMR Airports, South Indian Bank, suggets analyst

Technical picks: Jatin Gedia of Teji Mandi Investment Technologies suggests buying ACC, GMR Airports, South Indian Bank; here's why

Zee Ent up 12% on Unite8 Sports launch; in talks for FIFA World Cup rights

Zee Entertainment will launch Unite8 Sports 1 and Unite8 Sports 1 HD in Hindi, and Unite8 Sports 2 and Unite8 Sports 2 HD in English.

P&G Health stock surges 18% after solid Q4 results; PAT jumps 56% YoY

P&G Health reported a net profit of ₹95 crore, up 56 per cent Y-o-Y, driven by superior brand-building activities and supported by strengthened supply chain and go-to-market capabilities

Multibagger stock: HFCL hits 52-wk high, jumps 9% on ₹135-cr RailTel order

Today's buying interest in HFCL was buoyed by an announcement wherein the company has received a purchase order worth ₹135.09 crore from RailTel Corporation.

Jupiter Wagons rises 6% on inking long-term supply pact with Tatravagonka

Jupiter Tatravagonka Railwheel Factory Pvt. Ltd. (JTRWF) has entered into a definitive long-term supply agreement with European rail wagon manufacturer Tatravagonka a.s.

Max India shares jump 16% as partial OC unlocks ₹150 crore receivables

The buying on the counter came after Contend Builders, a joint venture company of Antara Senior Living, a subsidiary of Max India, received a partial OC for its senior living community at Noida

Ceat flags near-term margin pressure; brokerages split on outlook

Ceat laid out its growth and margin roadmap at its investor meet held on 26 May 2026, flagging near-term pressure from raw material cost inflation

Gujarat Fluorochemicals falls 6% after Q4 PAT miss; brokerages cut ratings

Gujarat Fluorochemicals reported a revenue from operations of ₹1,369 crore, up 12 per cent from ₹1,255 crore in the year-ago period

Aequs tumbles 10% after Q4 Ebitda miss; JM Financial downgrades to 'Reduce'

Aequs earnings before interest, tax, depreciation, and amortisation (Ebitda) declined 23 per cent year-on-year to ₹321 crore from ₹416 crore in the year-ago period.

AstraZeneca Pharma shares slip 6% on posting 23% fall in Q4 profit YoY

In the March quarter, AstraZeneca Pharma reported a 23 per cent year-on-year (Y-o-Y) decline in consolidated net profit to ₹44.9 crore, from ₹58.25 crore a year ago

Siemens up 3% after Q4; orders beat, margins miss; Nomura stays 'Neutral'

In the quarter under review, Siemens reported consolidated net profit of ₹ 370.1 crore, down 36.4 per cent year-on-year (Y-o-Y) from ₹ 582 crore a year ago.